Sequana Medical NV: Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION 18 March 2022, 6 p.m. CET Ghent, Belgium - 18 March 2022 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical")

Related Keywords

Jersey ,Norway ,Australia ,United States ,New Zealand ,Hong Kong ,United Kingdom ,Israel ,Belgium ,China ,Canada ,Switzerland ,Belgian ,American ,Dina Chaya ,Newton Biocapital ,Maatschap Chione ,Guillaume Van Renterghem ,Belgian Companies ,Neomed Iv Extension Limited ,Neomed Management Jersey Limited ,Belgian Financial Services ,Neomed Innovationv Limited ,Neomed Iv Extension Limited Innovation ,Company Or Sequanamedical ,Euronext Brussels ,Neomed Management ,Erik Amble ,Claudio Nessi ,Rudi De Winter ,Belgian Act ,Sequana Medical ,Belgian Transparency Act ,Markets Authority ,Direct Sodium Removal ,North American ,Regulatory Disclaimers ,Sequana ,Medical ,Transparency ,Notifications ,Rom ,Shareholders ,